The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency

References

• Chronic obstructive pulmonary disease (COPD) [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2013. [cited 2014 Nov 26]. Available from: http://www.cdc.gov/copd/index.htm
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults – United States, 2011. MMWR Morb Mortal Wkly Rep. 2012 Nov 23;61(46):938–943.
   PubMedGoogle Scholar
• Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012 Oct 10;61(6):1–51.
   PubMedGoogle Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007 Sep 15;176(6):532–555.
   PubMed Web of Science ®Google Scholar
• Ford ES, Murphy LB, Khavjou O, et al. Total and state-specific medical and absenteeism costs of COPD among adults aged 18 years in the United States for 2010 and projections through 2020. Chest. 2015 Jan;147(1):31–45.
   PubMed Web of Science ®Google Scholar
• Landis SH, Muellerova H, Mannino DM, et al. Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597–611.
   PubMed Web of Science ®Google Scholar
• Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med. 2005 Dec;118(12):1415.
   PubMedGoogle Scholar
• Foreman MG, Campos M, Celedón JC. Genes and chronic obstructive pulmonary disease. Med Clin North Am. 2012 Jul;96(4):699–711.
   PubMed Web of Science ®Google Scholar
• Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest. 1986 Mar;89(3):370–373.
   PubMed Web of Science ®Google Scholar
• Gadek JE, Fells GA, Zimmerman RL, et al. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest. 1981 Oct;68(4):889–898.
   PubMed Web of Science ®Google Scholar
• Brantly ML, Wittes JT, Vogelmeier CF, et al. Use of a highly purified α1-antitrypsin standard to establish ranges for the common normal and deficient α1-antitrypsin phenotypes. Chest. 1991 Sep;100(3):703–708.
   PubMed Web of Science ®Google Scholar
• Vijayasaratha K, Stockley RA. Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:789–796.
   PubMed Web of Science ®Google Scholar
• de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest. 2002 Nov;122(5):1818–1829.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003 Oct 1;168(7):818–900.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Sandhaus RA, Turino G, et al. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest. 2005 Oct;128(4):1989–1994.
   PubMed Web of Science ®Google Scholar
• White P. Prevalence of COPD in primary care: no room for complacency. Fam Pract. 2009 Feb;26(1):1–2.
   PubMed Web of Science ®Google Scholar
• Kelbel T, Morris D, Walker D, et al. The Allergist’s role in detection of severe alpha-1 antitrypsin deficiency. J Allergy Clin Immunol Pract. 2017 Sep–Oct;5(5):1302–1306.
   PubMed Web of Science ®Google Scholar
• Walters JA, Walters EH, Nelson M, et al. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J. 2011 Dec;20(4):396–402.
   PubMedGoogle Scholar
• Ely JW, Kaldjian LC, D’Alessandro DM. Diagnostic errors in primary care: lessons learned. J Am Board Fam Med. 2012 Jan–Feb;25(1):87–97.
   PubMed Web of Science ®Google Scholar
• Chakraborty P, Teckman J. Alpha-1-antitrypsin deficiency liver disease: science and therapeutic potential 50 years later. J Gastroenterol Pancreatol Liver Disord. 2014;1(3):1–9.
   Google Scholar
• Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax. 2004 Feb;59(2):164–169.
   PubMed Web of Science ®Google Scholar
• Blanco I, Bueno P, Diego I, et al. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update. Int J Chron Obstruct Pulmon Dis. 2017;12:561–569.
   PubMed Web of Science ®Google Scholar
• Blanco I, Bueno P, Diego I, et al. Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide. Int J Chron Obstruct Pulmon Dis. 2017;12:1683–1694.
   PubMed Web of Science ®Google Scholar
• Bornhorst JA, Greene DN, Ashwood ER, et al. α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population. Chest. 2013 Apr;143(4):1000–1008.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Lacbawan FL, Aboussouan LS. Alpha-1 antitrypsin deficiency. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews(R). Seattle (WA): University of Washington; 1993–2017.
   Google Scholar
• Teckman JH. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study. J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):34–37.
   PubMed Web of Science ®Google Scholar
• de Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med. 2014 Oct;276(4):311–335.
   PubMed Web of Science ®Google Scholar
• Jordan RE, Adab P, Jowett S, et al. TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol. BMC Pulm Med. 2014 Oct 4;14:157.
   PubMed Web of Science ®Google Scholar
• Perlmutter DH. Alpha-1-antitrypsin deficiency: diagnosis and treatment. Clin Liver Dis. 2004 Nov;8(4):839–859, viii–ix.
   PubMedGoogle Scholar
• Strange C, Stoller JK, Sandhaus RA, et al. Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration. 2006;73(2):185–190.
   PubMed Web of Science ®Google Scholar
• Fregonese L, Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008 Jun 19;3:16.
   PubMed Web of Science ®Google Scholar
• Campos MA, Wanner A, Zhang G, et al. Trends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003. Chest. 2005 Sep;128(3):1179–1186.
   PubMed Web of Science ®Google Scholar
• Lomas DA. New insights into the structural basis of 1,-antitrypsin deficiency. QJM. 1996 Nov;89(11):807–812.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Lieberman J, Gaidulis L, et al. Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1324–1328.
   PubMed Web of Science ®Google Scholar
• Puri P, Chandra A. Autophagy modulation as a potential therapeutic target for liver diseases. J Clin Exp Hepatol. 2014 Mar;4(1):51–59.
   PubMedGoogle Scholar
• Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976 Jun 10;294(24):1316–1321.
   PubMed Web of Science ®Google Scholar
• Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand. 1978;204(5):345–351.
   PubMed Web of Science ®Google Scholar
• Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med. 1986 Mar 20;314(12):736–739.
   PubMed Web of Science ®Google Scholar
• Pini L, Tiberio L, Venkatesan N, et al. The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. Respir Res. 2014 Sep 14;15(1):112.
   PubMed Web of Science ®Google Scholar
• Blanco I, Lipsker D, Lara B, et al. Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update. Br J Dermatol. 2016 Apr;174(4):753–762.
   PubMed Web of Science ®Google Scholar
• Serra HG, Bertuzzo CS, Pereira MC, et al. Determination of alpha 1-antitrypsin levels and of the presence of S and Z alleles in a population of patients with chronic respiratory symptoms. J Bras Pneumol. 2008 Dec;34(12):1019–1025.
   PubMedGoogle Scholar
• Mahr AD, Edberg JC, Stone JH, et al. Alpha(1)-antitrypsin deficiency-related alleles Z and S and the risk of Wegener’s granulomatosis. Arthritis Rheum. 2010 Dec;62(12):3760–3767.
   PubMed Web of Science ®Google Scholar
• Blanco I. Clinical diagnosis. In: Blanco’s overview of alpha-1 antitrypsin deficiency: history, biology, pathophysiology, related diseases, diagnosis and treatment. Academic Press, Elsevier; 2017. p. 115–128.
   Google Scholar
• Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008 May;63(5):402–407.
   PubMed Web of Science ®Google Scholar
• Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006 Dec;61(12):1043–1047.
   PubMed Web of Science ®Google Scholar
• Price D, Freeman D, Cleland J, et al. Earlier diagnosis and earlier treatment of COPD in primary care. Prim Care Respir J. 2011 Mar;20(1):15–22.
   PubMedGoogle Scholar
• Stoller JK. Detecting alpha-1 antitrypsin deficiency. Ann Am Thorac Soc. 2016 Aug;13(Suppl 4):S317–S325.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Fromer L, Brantly M, et al. Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities. Cleve Clin J Med. 2007 Dec;74(12):869–874.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Smith P, Yang P, et al. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med. 1994 Nov-Dec;61(6):461–467.
   PubMed Web of Science ®Google Scholar
• Holm KE, Borson S, Sandhaus RA, et al. Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD. COPD. 2013 Apr;10(2):226–234.
   PubMedGoogle Scholar
• de Serres FJ, Blanco I, Fernández-Bustillo E. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening. COPD. 2006 Aug;3(3):133–139.
   PubMedGoogle Scholar
• Marvel J, Yu TC, Wood R, et al. The diagnosis and management of alpha-1 antitrypsin deficiency in the adult. Chronic Obstr Pulm Dis. 2016 Jun 06;3(3):668–682.
   PubMedGoogle Scholar
• Chapman KR, Bourbeau J, Rance L. The burden of COPD in Canada: results from the Confronting COPD survey. Respir Med. 2003 Mar;97(Suppl C):S23–31.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W, Agusti A, et al.; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004 Jun;23(6):932–946.
   PubMed Web of Science ®Google Scholar
• U. S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008 Apr 1;148(7):529–534.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009 Aug 29;374(9691):721–732.
   PubMed Web of Science ®Google Scholar
• Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997;75(5):397–415.
   PubMed Web of Science ®Google Scholar
• Siri D, Farah H, Hogarth DK. Distinguishing alpha1-antitrypsin deficiency from asthma. Ann Allergy Asthma Immunol. 2013 Dec;111(6):458–464.
   PubMed Web of Science ®Google Scholar
• Ferrarotti I, Scabini R, Campo I, et al. Laboratory diagnosis of alpha1-antitrypsin deficiency. Transl Res. 2007 Nov;150(5):267–274.
   PubMed Web of Science ®Google Scholar
• Piitulainen E, Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Respir J. 1999 Feb;13(2):247–251.
   PubMed Web of Science ®Google Scholar
• Seersholm N, Kok-Jensen A, Dirksen A. Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1922–1925.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The lung health study. JAMA. 1994 Nov 16;272(19):1497–1505.
   PubMed Web of Science ®Google Scholar
• Wang C-S, Wang S-T, Lai C-T, et al. Impact of influenza vaccination on major cause-specific mortality. Vaccine. 2007 Jan 26;25(7):1196–1203.
   PubMed Web of Science ®Google Scholar
• van der Molen T. Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J. 2010 Dec;19(4):326–334.
   PubMedGoogle Scholar
• Silverman EK, Province MA, Campbell EJ, et al. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits. Genet Epidemiol. 1992;9(5):317–331.
   PubMed Web of Science ®Google Scholar
• Kueppers F, Sanders C. State-of-the-art testing for alpha-1 antitrypsin deficiency. Allergy Asthma Proc. 2017 Mar 24;38(2):108–114.
   PubMed Web of Science ®Google Scholar
• Ottaviani S, Gorrini M, Scabini R, et al. C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. Transl Res. 2011 Jun;157(6):332–338.
   PubMed Web of Science ®Google Scholar
• Molina J, Flor X, García R, et al. The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting. Ther Adv Respir Dis. 2011 Aug;5(4):237–243.
   PubMedGoogle Scholar
• Nolte JL, Ataya A, Merrill H, et al. Alpha1-antitrypsin deficiency-increased knowledge and diagnostic testing after viewing short instructional video. COPD. 2017 Feb;14(1):52–55.
   PubMedGoogle Scholar
• Campos M, Hagenlocker B, Martinez N, et al. Impact of an electronic medical record clinical reminder to improve detection of COPD and alpha-1 antitrypsin deficiency in the veterans administration system. Am J Respir Crit Care Med. 2011;183(A):5356.
   Google Scholar
• Liu F, Zou Y, Huang Q, et al. Electronic health records and improved nursing management of chronic obstructive pulmonary disease. Patient Prefer Adherence. 2015;9:495–500.
   PubMed Web of Science ®Google Scholar
• Luna Diaz LV, Iupe I, Zavala B, et al. Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory. Int J Chron Obstruct Pulmon Dis. 2017;12:2257–2259.
   PubMed Web of Science ®Google Scholar
• Teckman J, Pardee E, Howell RR, et al. Appropriateness of newborn screening for alpha1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):199–203.
   PubMed Web of Science ®Google Scholar
• Encouraging people to stop smoking [Internet]. World Health Organization – Department of Mental Health and Substance Dependence. 2001. [cited 2015 Jun 15]. Available from: http://www.who.int/mental_health/evidence/stop_smoking_whomsdmdp01_4.pdf
   Google Scholar
• Campos MA, Alazemi S, Zhang G, et al. Effects of a disease management program in individuals with alpha-1 antitrypsin deficiency. COPD. 2009 Feb;6(1):31–40.
   PubMedGoogle Scholar
• Chapman KR, Burdon JG, Piitulainen E, et al. Intravenous augmentation treatment and lung density in severe alpha1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Lancet. 2015 May 27;386(9991):360–368.
   PubMed Web of Science ®Google Scholar
• Chapman KR, Stockley RA, Dawkins C, et al. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD. 2009 Jun;6(3):177–184.
   PubMedGoogle Scholar
• Blanco I, Lara B, de Serres F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis. 2011 Apr 12;6:14.
   PubMed Web of Science ®Google Scholar
• Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report–2010. J Heart Lung Transplant. 2010 Oct;29(10):1104–1118.
   PubMed Web of Science ®Google Scholar
• Tanash HA, Riise GC, Hansson L, et al. Survival benefit of lung transplantation in individuals with severe α1-anti-trypsin deficiency (PiZZ) and emphysema. J Heart Lung Transplant. 2011 Dec;30(12):1342–1347.
   PubMed Web of Science ®Google Scholar
• Kayler LK, Merion RM, Lee S, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant. 2002 Aug;6(4):295–300.
   PubMed Web of Science ®Google Scholar
• Francavilla R, Castellaneta SP, Hadzic N, et al. Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J Hepatol. 2000 Jun;32(6):986–992.
   PubMed Web of Science ®Google Scholar
• Nelson DR, Teckman J, Di Bisceglie AM, et al. Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency. Clin Gastroenterol Hepatol. 2012 Jun;10(6):575–580.
   PubMed Web of Science ®Google Scholar